I Compared 11 Compounded Tirzepatide Providers and Most Are More Similar Than They Want You to Think

Most coverage of this space treats every telehealth GLP-1 brand as interchangeable, with minor pricing differences. That’s not quite right. The real gaps are in pharmacy transparency, state availability, monitoring depth, and what happens when the FDA tightens compounding rules again. Those differences matter a lot more than a slick app.

What I Looked At

Before getting into the list, here is the short version of my criteria:

• Cash pricing for compounded tirzepatide specifically
• Pharmacy identity and compliance (503A vs. unnamed, USP-797, lot tracking)
• Physician oversight model (rubber-stamp or actual review)
• Shipping speed and state coverage
• Monitoring and support depth
• Transparency (lab testing, ingredient sourcing, fee structure)

I am not a doctor. Nothing here is medical advice, and compounded tirzepatide is not FDA-approved regardless of who dispenses it.

The 11 Providers

1. HealthRX

For cash-pay buyers who want compounded tirzepatide without a subscription maze, HealthRX is the clearest starting point I found. Tirzepatide starts at $149 per month, semaglutide at $99. Those are among the lowest published prices in this category, and the pricing is posted upfront with no hidden fees. Overnight shipping is free to all 50 states. The pharmacy behind it is Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-tracked batches from compounding bench to your door. That is more pharmacy specificity than most competitors offer. HealthRX holds LegitScript certification (cert 50087439). A US board-certified physician reviews your intake within roughly 24 hours. The clinical trial data it references is legitimate: SURMOUNT-1 showed approximately 21% average body weight reduction with tirzepatide over 72 weeks. HealthRX does not claim its compound is equivalent to Mounjaro or any branded product, which is the legally correct position. Best fit: someone who wants low cash pricing, named pharmacy compliance, and fast turnaround without a coaching program attached.

2. FormBlends

FormBlends earns a spot here for a different kind of buyer. It dispenses compounded GLP-1s through an FDA-registered 503A pharmacy and publishes actual purity testing data per product, including HPLC purity figures, mass spectrometry identity confirmation, and endotoxin and sterility results with named numbers. That level of public documentation is rare. Tirzepatide runs around $349 per vial and semaglutide around $299, so it is a higher price point than HealthRX. Shipping covers 47 states. The bigger differentiator is the catalog: FormBlends also carries peptides for recovery, longevity, and cognitive support under the same clinician oversight model, so someone managing multiple peptide protocols can consolidate providers. It does not win on entry price. It wins on lab documentation and breadth. If published purity data is your deciding factor, FormBlends is worth a serious look.

3. Mochi Health

Mochi uses board-certified obesity-medicine physicians, not general practitioners, which is a meaningful distinction in this category. Compounded tirzepatide is $199 per month and compounded semaglutide is $99. The monitoring structure is heavier than budget-tier options. It is a good middle ground between price and clinical depth.

4. Henry Meds

Henry keeps costs low at roughly $179 to $249 for the first month and emphasizes fast shipping, often 24 to 72 hours. It is cash-pay focused and lighter on the monitoring side. Good for someone who wants speed and simplicity without a long onboarding process.

5. MEDVi

MEDVi offers compounded tirzepatide at around $179 for the first month with no contracts. That flexibility is genuinely useful if you want to test a provider before committing. Physician oversight is included. Monitoring is basic.

6. Eden

Eden’s compounded semaglutide starts at about $149 per month cash. Tirzepatide pricing varies. It is a streamlined platform, reasonably priced, and works for straightforward cases. Less depth on the clinical support side.

7. Ro Body

Ro’s membership starts at $39 for the first month, then $74 to $149 per month, with medications billed separately. It has a dedicated prior-authorization team and accepts insurance for branded medications. More infrastructure than most.

8. Found

Found charges roughly $99 per month for the platform plus medication costs separately. It adds behavioral coaching to the medication model. Better for people who want accountability structure alongside prescriptions.

9. PlushCare

PlushCare is primarily an insurance-friendly telehealth platform with a $19.99 monthly membership. Same-day visits are available. It focuses on branded medications and insurance billing rather than compounded options.

10. WeightWatchers Clinic

The WW Clinic charges about $74 per month for the program fee with medications added separately. The brand recognition brings a large community element. It is not a compounding-first platform.

11. Calibrate

Calibrate runs a roughly 12-month program with coaching, labs, and medication costs separate from the program fee. It is the most intensive model on this list in terms of time and total cost. Best suited to someone who wants a full structured intervention rather than a prescription service.

How to Choose

Price alone is a bad filter. At $149 per month, HealthRX is hard to beat on value if you want compounded tirzepatide with pharmacy transparency and 50-state access. If you want published purity documentation or a provider that also covers a wider peptide catalog, FormBlends is the upgrade pick at a higher price. If you want deeper clinical monitoring, Mochi is worth the extra cost. And if insurance coverage for branded medications matters most, Ro or PlushCare are the better fits.

The FDA’s compounding rules are still shifting. Any provider you choose should be able to name their pharmacy and show compliance documentation. If they cannot, that is a real red flag.

Common Questions

Does it matter whether a compounded tirzepatide provider uses a 503A or 503B pharmacy?

Yes, it matters practically. A 503A pharmacy compounds for individual patients under a valid prescription and operates under state board oversight. A 503B outsourcing facility produces larger batches under FDA inspection. Both are legal frameworks, but 503B facilities face more frequent federal scrutiny. Ask which type your provider uses before ordering.

What does HPLC purity documentation actually tell you about a compounded tirzepatide product?

High-performance liquid chromatography separates the compound’s components and measures their concentrations. A published HPLC result with a specific purity percentage, say 98.5%, tells you the active ingredient is present at that level and that major impurities were measured. Without that number, a provider’s general quality claim is unverifiable. FormBlends publishes these figures; most providers do not.

If the FDA restricts compounding again, which providers on this list are best positioned to adapt?

Providers tied to named, compliant 503A pharmacies with documented lot tracking, like HealthRX with Manifest Pharmacy, have a clearer compliance paper trail. Providers that obscure their pharmacy source have less to show regulators if rules tighten. No provider is immune to an FDA shortage-list change, but transparency now is a reasonable proxy for resilience later.

Can Mochi Health’s obesity-medicine physicians actually adjust your protocol, or is the prescribing mostly automated?

Mochi’s model uses board-certified obesity-medicine specialists rather than general practitioners, which means the prescriber has formal training in dosing adjustments, plateau management, and contraindication review. That is a structural difference from platforms where intake questionnaires drive most decisions. Whether any individual physician takes a hands-on approach still depends on the specific clinician assigned to your case.

Why does HealthRX’s pricing come in lower than FormBlends when both use 503A pharmacies?

Pricing reflects more than pharmacy type. FormBlends publishes extensive third-party lab documentation per batch and carries a broader peptide catalog, both of which add operational cost. HealthRX focuses narrowly on GLP-1 compounds and passes a leaner cost structure to the patient. Lower price does not mean lower quality here, it means a different scope of service and documentation depth.

Sources

• FDA compounding guidance and 503A framework, FDA.gov
• SURMOUNT-1 trial results (tirzepatide), published in *New England Journal of Medicine*, 2022
• STEP 1 trial results (semaglutide), published in *New England Journal of Medicine*, 2021
• LegitScript compounding pharmacy certification database, LegitScript.com
• Novo Nordisk compounded semaglutide settlement reporting, *Reuters* and *STAT News*, March 2026
• Lilly orforglipron announcement and LillyDirect pricing, Eli Lilly press releases, April 2026